Relmada Therapeutics, Inc. (RLMD) SEC filings
RLMD SEC filings moved a median of -2.56% by the close. RLMD SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the RLMD overview →
59 measured RLMD SEC filing events.
Where these RLMD SEC filings landedvs 59 measured RLMD SEC filing reactions
| Middle 50% of RLMD SEC filing reactions | -6.83% to +0.54% |
|---|---|
| Median reaction (to close) | -2.56% |
| Measured reactions | 59 |
Point-in-time · zero look-ahead
Half of the 59 RLMD SEC filing events with a measured close landed between -6.83% and +0.54%; 31% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K RELMADA THERAPEUTICS, For: Sep 03 | SEC filing · Form 8-K | -1.79% | -3.41% | |
| Form 10-Q RELMADA THERAPEUTICS, For: Jun 30 | SEC filing · Form 10-Q | -5.77% | -10.99% | |
| Form 8-K RELMADA THERAPEUTICS, For: Aug 06 | SEC filing · Form 8-K | -5.77% | -10.99% | |
| Form 8-K RELMADA THERAPEUTICS, For: Jul 28 | SEC filing · Form 8-K | +0.29% | +1.55% | |
| Form S-8 RELMADA THERAPEUTICS, | SEC filing · Form S-8 | +1.04% | +2.07% | |
| Form 8-K RELMADA THERAPEUTICS, For: May 27 | SEC filing · Form 8-K | -0.14% | +0.14% | |
| Form S-3ASR RELMADA THERAPEUTICS, | SEC filing · Form S-3ASR | -1.33% | -1.07% | |
| Form 10-Q RELMADA THERAPEUTICS, For: Mar 31 | SEC filing · Form 10-Q | +1.07% | +0.54% | |
| Form 8-K RELMADA THERAPEUTICS, For: May 12 | SEC filing · Form 8-K | +1.07% | +0.54% | |
| Form DEF 14A RELMADA THERAPEUTICS, For: May 27 | SEC filing · Form DEF | -0.54% | -1.34% | |
| Form DEFA14A RELMADA THERAPEUTICS, | SEC filing · Form DEFA14A | -0.54% | -1.34% | |
| Form EFFECT RELMADA THERAPEUTICS, | SEC filing · Form EFFECT | -1.17% | -5.57% | |
| Form PRE 14A RELMADA THERAPEUTICS, For: Apr 06 | SEC filing · Form PRE | -1.47% | -0.73% | |
| Form S-3 RELMADA THERAPEUTICS, | SEC filing · Form S-3 | +1.74% | +0.29% | |
| Form 8-K RELMADA THERAPEUTICS, For: Mar 19 | SEC filing · Form 8-K | -1.98% | -3.46% | |
| Form 10-K RELMADA THERAPEUTICS, For: Dec 31 | SEC filing · Form 10-K | -1.23% | -6.62% | |
| Form 8-K RELMADA THERAPEUTICS, For: Mar 09 | SEC filing · Form 8-K | -1.86% | +11.16% | |
| Form 8-K RELMADA THERAPEUTICS, For: Dec 12 | SEC filing · Form 8-K | +0.00% | +5.83% | |
| Form 8-K RELMADA THERAPEUTICS, For: Nov 04 | SEC filing · Form 8-K | +5.10% | -1.57% | |
| Form 8-K RELMADA THERAPEUTICS, For: Nov 04 | SEC filing · Form 8-K | -0.45% | +25.34% | |
| Form 8-K RELMADA THERAPEUTICS, For: Sep 17 | SEC filing · Form 8-K | -0.61% | -7.36% | |
| Form 8-K RELMADA THERAPEUTICS, For: Sep 15 | SEC filing · Form 8-K | +7.06% | -5.88% | |
| Form 8-K RELMADA THERAPEUTICS, For: Sep 10 | SEC filing · Form 8-K | +0.32% | +3.21% | |
| Form 8-K RELMADA THERAPEUTICS, For: Aug 29 | SEC filing · Form 8-K | -2.14% | +25.66% | |
| Form 10-Q RELMADA THERAPEUTICS, For: Jun 30 | SEC filing · Form 10-Q | +0.77% | -1.28% | |
| Form 8-K RELMADA THERAPEUTICS, For: Aug 07 | SEC filing · Form 8-K | +0.77% | -1.28% | |
| Form 8-K RELMADA THERAPEUTICS, For: Jul 22 | SEC filing · Form 8-K | -1.86% | -7.04% | |
| Form 8-K RELMADA THERAPEUTICS, For: Jul 07 | SEC filing · Form 8-K | -2.94% | -10.75% | |
| Form 8-K RELMADA THERAPEUTICS, For: Jun 17 | SEC filing · Form 8-K | -1.42% | -0.72% | |
| Form S-8 RELMADA THERAPEUTICS, | SEC filing · Form S-8 | -1.03% | +2.97% | |
| Form 8-K RELMADA THERAPEUTICS, For: May 23 | SEC filing · Form 8-K | -3.77% | +5.06% | |
| Form 10-Q RELMADA THERAPEUTICS, For: Mar 31 | SEC filing · Form 10-Q | +0.13% | +0.93% | |
| Form 8-K RELMADA THERAPEUTICS, For: May 08 | SEC filing · Form 8-K | +0.13% | +0.93% | |
| Form 8-K RELMADA THERAPEUTICS, For: Apr 28 | SEC filing · Form 8-K | -6.43% | -50.20% | |
| Form DEF 14A RELMADA THERAPEUTICS, For: May 23 | SEC filing · Form DEF | -5.80% | -7.64% | |
| Form DEFA14A RELMADA THERAPEUTICS, | SEC filing · Form DEFA14A | -5.80% | -7.64% | |
| Form 10-K RELMADA THERAPEUTICS, For: Dec 31 | SEC filing · Form 10-K | -6.84% | -4.69% | |
| Form 8-K RELMADA THERAPEUTICS, For: Mar 27 | SEC filing · Form 8-K | -6.84% | -4.69% | |
| Form 8-K RELMADA THERAPEUTICS, For: Mar 24 | SEC filing · Form 8-K | -0.19% | -5.40% | |
| Form 8-K RELMADA THERAPEUTICS, For: Feb 03 | SEC filing · Form 8-K | -10.04% | -28.00% | |
| Form 8-K RELMADA THERAPEUTICS, For: Jan 21 | SEC filing · Form 8-K | +1.50% | -3.69% | |
| Form 8-K RELMADA THERAPEUTICS, For: Jan 01 | SEC filing · Form 8-K | +1.20% | +7.86% | |
| Form 8-K RELMADA THERAPEUTICS, For: Dec 09 | SEC filing · Form 8-K | -3.79% | -3.61% | |
| Form 8-K RELMADA THERAPEUTICS, For: Dec 04 | SEC filing · Form 8-K | -1.29% | -9.35% | |
| Form 10-Q RELMADA THERAPEUTICS, For: Sep 30 | SEC filing · Form 10-Q | -1.85% | +0.92% | |
| Form EFFECT RELMADA THERAPEUTICS, | SEC filing · Form EFFECT | +0.00% | -4.92% | |
| Form S-3 RELMADA THERAPEUTICS, | SEC filing · Form S-3 | +0.00% | -2.14% | |
| Form 10-Q RELMADA THERAPEUTICS, For: Jun 30 | SEC filing · Form 10-Q | -4.98% | -28.35% | |
| Form 8-K RELMADA THERAPEUTICS, For: May 24 | SEC filing · Form 8-K | +0.00% | +1.01% | |
| Form 10-Q RELMADA THERAPEUTICS, For: Mar 31 | SEC filing · Form 10-Q | +1.28% | -2.56% | |
| Form DEF 14A RELMADA THERAPEUTICS, For: May 24 | SEC filing · Form DEF | +1.68% | -5.45% | |
| Form DEFA14A RELMADA THERAPEUTICS, | SEC filing · Form DEFA14A | +1.68% | -5.45% | |
| Form 10-K RELMADA THERAPEUTICS, For: Dec 31 | SEC filing · Form 10-K | +0.00% | -19.51% | |
| Form 8-K RELMADA THERAPEUTICS, For: Mar 19 | SEC filing · Form 8-K | +0.00% | -19.51% | |
| Form 8-K RELMADA THERAPEUTICS, For: Jan 05 | SEC filing · Form 8-K | +3.01% | -5.71% | |
| Form 8-K RELMADA THERAPEUTICS, For: Jan 04 | SEC filing · Form 8-K | -3.90% | -31.22% | |
| Form 8-K RELMADA THERAPEUTICS, For: Jan 03 | SEC filing · Form 8-K | -3.90% | -31.22% | |
| Form 10-Q RELMADA THERAPEUTICS, For: Sep 30 | SEC filing · Form 10-Q | +2.66% | -0.66% | |
| Form 8-K RELMADA THERAPEUTICS, For: Nov 08 | SEC filing · Form 8-K | +2.66% | -0.66% |
Keep exploring
More RLMD: earnings → · analyst actions → · RLMD overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| EVOTEC AG S/ADR (EVTCY) | 265 | 0.00% | 17% |
| MiMedx Group, Inc (MDXG) | 265 | +0.14% | 57% |
| HUTCHMED (China) Limited - American Depositary Shares (HCM) | 263 | 0.00% | 47% |
| iBio, Inc. (IBIO) | 263 | -0.38% | 43% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.